Cause of death, by non-communicable diseases, ages 15-59 in Sri Lanka
Sri Lanka: Cause of death, by non-communicable diseases, ages 15-59 was 59.8% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 15-59 in Sri Lanka, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 15-59.
Analysis
Sri Lanka recorded 59.8% for cause of death, by non-communicable diseases, ages 15-59 in 2021.
Compared with earlier readings it is down 12.6% on the previous year and up 9.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 15-59 in Sri Lanka peaked at 69.8% in 2015 and was at its lowest, 54.6%, in 2010.
That places Sri Lanka 72nd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 15-59 in Sri Lanka, year by year
| Year | % of total deaths ages 15-59 | Change |
|---|---|---|
| 2000 | 56.4% | — |
| 2010 | 54.6% | -3.2% |
| 2015 | 69.8% | +27.8% |
| 2019 | 67.6% | -3.1% |
| 2020 | 68.4% | +1.2% |
| 2021 | 59.8% | -12.6% |
Sri Lanka compared with similar countries
- Sri Lanka's 59.8% is above the median for upper middle income countries, which is 53.8%, 1.1× the median. (55 countries reporting)
- Sri Lanka's 59.8% is above the median for South Asia, which is 54.0%, 1.1× the median. (6 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 56.4% | 56.4% | 56.4% | 1 |
| 2010s | 64.0% | 54.6% | 69.8% | 3 |
| 2020s | 64.1% | 59.8% | 68.4% | 2 |
Countries ranked near Sri Lanka
More health data for Sri Lanka
- Un projection of annual infant deaths, annual growth rate -1.62 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,250 deaths per 1,000 people (2090)
- Number of infants who die before age 1 304 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.13 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0339 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.12 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 15-59 in Sri Lanka?
- Cause of death, by non-communicable diseases, ages 15-59 in Sri Lanka was 59.8% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 15-59 recorded in Sri Lanka?
- The highest recorded value was 69.8% in 2015.
- What is the lowest cause of death, by non-communicable diseases, ages 15-59 recorded in Sri Lanka?
- The lowest recorded value was 54.6% in 2010.
- How does Sri Lanka rank for cause of death, by non-communicable diseases, ages 15-59?
- Sri Lanka ranks 72nd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 15-59 rising or falling in Sri Lanka?
- Over the last ten years it is up 9.5%. The long-run trend across the full record is rising.
- Where does this Sri Lanka data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.